Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
report crawled date : 2020 - 12 - 01 save search
Predictive Oncology Reports 2019 Full-year Financial Results
Published: 2020-04-01 (Crawled : 22:17) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K
|
Health Technology
|
| O: -6.68%
H: 5.1%
C: -4.76%
results
Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update
Published: 2020-06-08 (Crawled : 22:17) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K
|
Health Technology
|
| O: -1.65%
H: 7.26%
C: 2.23%
results
Predictive Oncology Reports Second Quarter 2020 Financial Results, Provides Business Update
Published: 2020-08-13 (Crawled : 22:17) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K
|
Health Technology
|
| O: -8.45%
H: 8.38%
C: 3.85%
results
Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report
Published: 2020-11-23 (Crawled : 22:16) - globenewswire.com
GENE | News | $2.36 -25.32% -33.9% 88K
|
Health Technology
|
| O: 2.19%
H: 0.0%
C: -6.13%
Westwater Resources Reports 2017 Results
Published: 2018-03-02 (Crawled : 22:16) - globenewswire.com
WWR 4 | $0.4497 -1.92% 2.02% 120K
|
Non-Energy Minerals
| Email alert
Add to watchlist
results report
Westwater Resources Announces the Completion of a New Technical Report on the Ambrosia Lake Uranium Project, McKinley County, New Mexico USA
Published: 2018-04-18 (Crawled : 22:16) - globenewswire.com
WWR 4 | $0.4497 -1.92% 2.02% 120K
|
Non-Energy Minerals
| Email alert
Add to watchlist
uranium
Westwater Resources Reports First Quarter 2018 Operating Results
Published: 2018-05-14 (Crawled : 22:16) - globenewswire.com
WWR 4 | $0.4497 -1.92% 2.02% 120K
|
Non-Energy Minerals
| Email alert
Add to watchlist
results
Westwater Resources Reports Second Quarter 2018 Operating Results
Published: 2018-08-09 (Crawled : 22:16) - globenewswire.com
WWR 4 | $0.4497 -1.92% 2.02% 120K
|
Non-Energy Minerals
| Email alert
Add to watchlist
results
Westwater Reports Increasing Strength in Uranium Market
Published: 2018-09-21 (Crawled : 22:16) - globenewswire.com
WWR 4 | $0.4497 -1.92% 2.02% 120K
|
Non-Energy Minerals
| Email alert
Add to watchlist
uranium report market
Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020
Published: 2020-04-23 (Crawled : 22:16) - globenewswire.com
DVAX | $11.35 -0.7% -0.7% 2.2M
|
Health Technology
|
| O: 4.44%
H: 0.57%
C: -3.68%
results
Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
Published: 2020-04-28 (Crawled : 22:16) - globenewswire.com
DVAX | $11.35 -0.7% -0.7% 2.2M
|
Health Technology
|
| O: 2.86%
H: 5.81%
C: 4.8%
hemodialysis trial ongoing
Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
Published: 2020-07-30 (Crawled : 22:16) - globenewswire.com
DVAX | $11.35 -0.7% -0.7% 2.2M
|
Health Technology
|
| O: -0.36%
H: 1.56%
C: -2.99%
results
HEXO Corp Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
Published: 2020-10-29 (Crawled : 22:16) - globenewswire.com
HEXO | $0.71 -0.14% 310K
|
Process Industries
| Email alert
Add to watchlist
results
Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
Published: 2020-05-14 (Crawled : 22:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 11.11%
H: 0.2%
C: -9.78%
results
Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results
Published: 2020-08-12 (Crawled : 22:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: -3.81%
results
Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Published: 2020-11-12 (Crawled : 22:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -8.36%
H: 0.97%
C: -1.08%
results
Corbus Pharmaceuticals Reports Last Subject Visit in RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
Published: 2020-05-27 (Crawled : 22:15) - globenewswire.com
CRBP M | $36.465 -1.87% -1.91% 130K
|
Health Technology
|
| O: 1.25%
H: 0.99%
C: -5.18%
sclerosis phase 3 treatment
Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Published: 2020-06-22 (Crawled : 22:15) - globenewswire.com
CRBP M | $36.465 -1.87% -1.91% 130K
|
Health Technology
|
| O: 1.43%
H: 2.25%
C: 0.64%
treatment phase 2b fibrosis cystic fibrosis
Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Sclerosis World E-Congress
Published: 2020-06-29 (Crawled : 22:15) - globenewswire.com
CRBP M | $36.465 -1.87% -1.91% 130K
|
Health Technology
|
| O: 0.64%
H: 5.22%
C: 0.76%
sclerosis
Corbus Pharmaceuticals to Report Second Quarter Results on August 6, 2020
Published: 2020-07-30 (Crawled : 22:15) - globenewswire.com
CRBP M | $36.465 -1.87% -1.91% 130K
|
Health Technology
|
| O: 0.16%
H: 7.91%
C: 3.41%
results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.